Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)

K Williams, A Brignell, M Randall… - Cochrane Database …, 2013 - cochranelibrary.com
Background Autism spectrum disorders (ASD) are characterised by abnormalities in social
interaction and communication skills, as well as stereotypic behaviours and restricted …

[PDF][PDF] The human cost of not achieving full remission in depression

RS McIntyre, C O'Donovan - Canadian Journal of Psychiatry, 2004 - Citeseer
Depression is among the most disabling and costly illnesses in the world. Despite good
short-term efficacy outcomes in the treatment of depression, long-term outcomes remain …

Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices—budget impact analysis

JA Mauskopf, SD Sullivan, L Annemans, J Caro… - Value in …, 2007 - Wiley Online Library
Objectives: There is growing recognition that a comprehensive economic assessment of a
new health‐care intervention at the time of launch requires both a cost‐effectiveness …

Quantitative analysis of sponsorship bias in economic studies of antidepressants

CB Baker, MT Johnsrud, ML Crismon… - The British Journal of …, 2003 - cambridge.org
BackgroundConcern is widespread about potential sponsorship influence on research,
especially in pharmacoeconomic studies. Quantitative analysis of possible bias in such …

Do productivity costs matter? The impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders

M Krol, J Papenburg, M Koopmanschap… - Pharmacoeconomics, 2011 - Springer
Background: When guidelines for health economic evaluations prescribe that a societal
perspective should be adopted, productivity costs should be included. However, previous …

Evidence of cost-effective treatments for depression: a systematic review

B Barrett, S Byford, M Knapp - Journal of affective disorders, 2005 - Elsevier
BACKGROUND: High levels of public spending, rising costs of treatments and scarcity of
mental health resources have intensified the need for information on the cost-effectiveness …

Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence

N Sartorius, TC Baghai, DS Baldwin… - International Journal …, 2007 - academic.oup.com
The criteria used to assess whether a problem is of public health importance (and therefore
should be a priority for health services) include the prevalence of the problem, the severity of …

[HTML][HTML] Vagus nerve stimulation for epilepsy and depression

AH Milby, CH Halpern, GH Baltuch - Neurotherapeutics, 2008 - Elsevier
Many patients with epilepsy suffer from persistent seizures despite maximal antiepileptic
drug (AED) therapy. Chronic, intermittent vagus nerve stimulation (VNS) has proven to be a …

Psychology, law, and the expert witness.

W Schofield - American Psychologist, 1956 - psycnet.apa.org
Stresses for the psychologist called on for expert testimony stem from (1) the general nature
of court procedure and (2) the" special stresses which inhere in the present position of …

Variability of cost‐effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability

M Barbieri, M Drummond, R Willke… - Value in …, 2005 - Wiley Online Library
Objectives: It has long been suggested that, whereas the results of clinical studies of
pharmaceuticals are generalizable from one jurisdiction to another, the results of economic …